ArticleBMC pediatrics2025
Hemodynamic profile of cerebral arteries using transcranial Doppler in children with sickle cell disease compared to children without sickle cell disease: Prospective analytical study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCerebral vasculopathy is a frequent and serious complication of major sickle cell disease syndromes. Transcerebral Doppler (TCD) can detect stenosis of the main arteries at the base of the skull before stroke occurs, and initiate therapy to avoid complications. The objective of the study is to evaluate and compare the hemodynamic profile of the middle cerebral artery using TCD in children with sickle cell disease compared to children without sickle cell disease.
methodProspective analytical study extended over a 6-month period from July 04, 2023 to December 28, 2023. The study population consisted of subjects followed for homozygous sickle cell disease SS and non-sickle cell subjects received at the above-mentioned centers, of all sexes, aged 2 to 16 years at most.
resultsWe recruited 182 children (52.2% male and 47.8% female) divided into 70 children with sickle cell disease and 112 children without sickle cell disease. The mean of Maximum systolic velocity (MSV) on the left was 85.0 ± 49.5 cm/s in sickle cell patients and 84.5 ± 17.8 cm/s in non-sickle cell patients. The mean of telediastolic velocity (TDV) was 40.9 ± 31.2 cm/s in sickle cell patients and 44.0 ± 15.8 cm/s in non-sickle cell patients. The mean maximum velocity (MMV) was 53.22 ± 39.0 cm/s in sickle cell patients and 57.5 ± 16.3 cm/s in non-sickle cell patients.
conclusionThe mean velocity of children with sickle cell disease was lower than that of non-sickle cell patients, and the peak systolic velocity of children with sickle cell disease was slightly higher than those of children without sickle cell disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.